In this episode of The Digital Executive Podcast, host Brian Thomas sits down with Vanessa Slowey, President and CEO of TelyRx, to explore what happens when a lifetime of lessons about access, infrastructure, and trust finally converge in one mission. Vanessa opens with a story that begins above a small-town pharmacy in Sligo, Ireland, where her father's philosophy was simple: if someone needs medication, you figure out how to get it to them. That instinct followed her through a career building mobile networks across some of the world's most challenging terrain — Papua New Guinea, the Caribbean, 27 markets across Latin America — before bringing her back to healthcare and TelyRx. She draws a sharp contrast between the two industries: in telecoms, the barrier to access was physical and required building infrastructure from scratch; in US healthcare, the infrastructure already exists, but patients still face enormous friction navigating providers, prescriptions, pharmacies, insurance, and delivery. The barrier is friction, not geography, and the solution is the same: build the infrastructure so the patient does not have to connect all the pieces themselves. She is candid about where TelyRx deliberately limits its scope — non-controlled, FDA-approved, everyday medications like inhalers — because clinical integrity and convenience are not in tension when the model is designed correctly, and trust is built by knowing exactly what the platform is and is not for. She closes with a vision of digital health where technology works invisibly in the background and patients experience something deceptively simple: they needed care, they could access it, they understood what it would cost, and they got their medication. That is the standard. And with roughly seventy percent of TelyRx patients returning, she argues the market is already voting for it. If you liked what you heard today, please leave us a review - Apple or Spotify. Learn more about your ad choices. Visit megaphone.fm/adchoices
